Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemophilia
Biotech
Novo adds pediatric data to bulging bag of hemophilia A evidence
Novo has bolstered the case for its near-approval candidate, linking the prospect to reductions in treated bleeds in children with hemophilia A.
Nick Paul Taylor
Feb 7, 2025 5:28am
Pfizer crashes Sangamo's stock by ending hem A gene therapy pact
Jan 2, 2025 6:08am
Roche culls ph. 3 Spark gene therapy in hemophilia
Dec 16, 2024 12:24pm
Centessa drops hemophilia B drug following Pfizer’s Hympavzi win
Nov 12, 2024 9:45am
Pfizer gene therapy reduces bleeds in ph. 3 hemophilia A trial
Jul 24, 2024 8:44am
Novo unwraps phase 3 data on rival to Roche in hemophilia A
Jun 24, 2024 5:26am
